Effectiveness of Enhanced Treatments for Drug Dependence
EETDD
Effectiveness of an Enhanced Adaptive Continuing Care Model for Cocaine Dependence
1 other identifier
interventional
150
1 country
1
Brief Summary
The purpose of this challenge grant is to conduct an initial test of a new, enhanced version of this protocol (telephone monitoring and counseling - enhanced, or TMAC-E), which has been modified to include the elements of our existing continuing care intervention plus patient-centered changes to boost patient involvement and community linkages. The investigators will recruit 150 cocaine dependent patients in publicly funded, community-based programs and randomize them to treatment as usual or the TMAC-E and follow them for 12 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Oct 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2009
CompletedFirst Submitted
Initial submission to the registry
June 24, 2010
CompletedFirst Posted
Study publicly available on registry
June 30, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2011
CompletedMarch 30, 2017
March 1, 2017
2 years
June 24, 2010
March 28, 2017
Conditions
Outcome Measures
Primary Outcomes (4)
Time Line Follow Back
abstinence from drug and alcohol use within each 3 month period of the follow-up (as indicated by the TLFB)
3 month
Time Line Follow Back
abstinence from drug and alcohol use within each 3 month period of the follow-up (as indicated by the TLFB)
6 month
Time Line Follow Back
abstinence from drug and alcohol use within each 3 month period of the follow-up (as indicated by the TLFB)
9 month
Time Line Follow Back
abstinence from drug and alcohol use within each 3 month period of the follow-up (as indicated by the TLFB)
12 month
Study Arms (2)
TAU
NO INTERVENTIONThis group is the control group by which we are comparing our intervention. This group will not receive an intervention from us but will continue to be treated at the Intensive Outpatient facility from which we recruited them.
Counseling (TMAC-E)
EXPERIMENTALThis telephone based intervention includes six factors to improve our extended treatment model: Incentive component; Patient choice; Provision of cell phones to those who need them; Social support and community resources; Positive recovery factors; and Outreach following dropout.
Interventions
Calls or in-person sessions, 1x weekly for first 8 weeks, then every other week up to a year. Step up session frequency if needed based on participants' ratio of protective and risk factors.
Eligibility Criteria
You may qualify if:
- (1) qualify for a DSM-IV diagnosis of cocaine dependence, with some cocaine use in the prior 6 months;
- (2) be 18 to 75 years of age;
- (3) have no current psychotic disorder or evidence of dementia severe enough to prevent participation in outpatient treatment;
- (4) have no acute medical problem requiring immediate inpatient treatment;
- (5) not be in methadone or other modes of Drug and Alcohol treatment, other than Intensive Outpatient Program;
- (6) be willing to be randomized and participate in research;
You may not qualify if:
- have a current psychotic disorder or evidence of dementia severe enough to prevent participation in outpatient treatment;
- have acute medical problem requiring immediate inpatient treatment;
- are in methadone or other modes of DA treatment, other than IOP;
- or cannot provide names of people who can get messages to them for follow up, in the event we cannot locate the participant at their original address and number. Also, if they are court mandated to treatment or otherwise considered a prisoner, they will be ineligible for the study as we have not applied for Subpart C approval.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 24, 2010
First Posted
June 30, 2010
Study Start
October 1, 2009
Primary Completion
October 1, 2011
Study Completion
October 1, 2011
Last Updated
March 30, 2017
Record last verified: 2017-03